Compare · RAL vs TMO
RAL vs TMO
Side-by-side comparison of Ralliant Corporation (RAL) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RAL and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $197.88B, about 25.2x RAL ($7.85B).
- Over the past year, RAL is up 50.3% and TMO is up 31.4% - RAL leads by 18.9 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 1 for RAL).
- TMO has more recent analyst coverage (25 ratings vs 14 for RAL).
- Company
- Ralliant Corporation
- Thermo Fisher Scientific Inc
- Price
- $70.16+4.83%
- $532.16-2.05%
- Market cap
- $7.85B
- $197.88B
- 1M return
- +2.10%
- +12.59%
- 1Y return
- +50.27%
- +31.37%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2025
- News (4w)
- 1
- 7
- Recent ratings
- 14
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest RAL
- Ralliant Announces Second Quarter 2026 Earnings Release and Conference Call Date
- SEC Form 4 filed by Chief Accounting Officer Osben Teo
- SEC Form 4 filed by SVP - Chief Technology Officer Kazmi Amir A.
- SEC Form 4 filed by SVP - Chief People Officer Bick Karen M.
- SEC Form 4 filed by SVP - Chief Financial Officer Reynolds Neill
- SEC Form 4 filed by SVP - Chief Legal Officer Boatman Jonathon E.
- SEC Form 4 filed by President and CEO Newcombe Tamara S.
- SEC Form 11-K filed by Ralliant Corporation
- Ralliant Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Worrell Brian was granted 3,225 shares, increasing direct ownership by 55% to 9,129 units (SEC Form 4)
Latest TMO
- Thermo Fisher Scientific Announces Quarterly Dividend
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Keith R. Alexandra
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- Bernstein resumed coverage on Thermo Fisher with a new price target
- SEC Form 11-K filed by Thermo Fisher Scientific Inc
- Piper Sandler initiated coverage on Thermo Fisher with a new price target